Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Newly approved monkeypox vaccine by Japan's KM Biologics sees immediate overseas demand By: FOX Business August 03, 2022 at 12:01 PM EDT A new monkeypox vaccine, manufactured by KM Biologics Co, a Japanese pharmaceutical company, is garnering overseas interest as the disease spreads around the globe. Japanese pharmaceuticals company KM Biologics Co has already seen overseas interest in its monkeypox vaccine which was recently approved by domestic regulators.KM Biologics, a unit of candy maker Meiji Holdings Co, has had "several inquiries from overseas" a company official told Reuters on Wednesday, declining to comment on any export plan for the shot.Japan's health ministry on Tuesday approved the company's freeze-dried smallpox vaccine LC16 KMB for use against monkeypox, after an experts panel recommended the move last week.Japan has had only two confirmed cases of monkeypox during the current global outbreak.MONKEYPOX: WHAT YOU MUST KNOW ABOUT THE VIRUS — AND HOW TO PROTECT YOURSELFBased in the southern prefecture of Kumamoto, KM Biologics mainly produces vaccines for humans and veterinary use. It has an inactivated COVID-19 shot currently in development. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Newly approved monkeypox vaccine by Japan's KM Biologics sees immediate overseas demand By: FOX Business August 03, 2022 at 12:01 PM EDT A new monkeypox vaccine, manufactured by KM Biologics Co, a Japanese pharmaceutical company, is garnering overseas interest as the disease spreads around the globe. Japanese pharmaceuticals company KM Biologics Co has already seen overseas interest in its monkeypox vaccine which was recently approved by domestic regulators.KM Biologics, a unit of candy maker Meiji Holdings Co, has had "several inquiries from overseas" a company official told Reuters on Wednesday, declining to comment on any export plan for the shot.Japan's health ministry on Tuesday approved the company's freeze-dried smallpox vaccine LC16 KMB for use against monkeypox, after an experts panel recommended the move last week.Japan has had only two confirmed cases of monkeypox during the current global outbreak.MONKEYPOX: WHAT YOU MUST KNOW ABOUT THE VIRUS — AND HOW TO PROTECT YOURSELFBased in the southern prefecture of Kumamoto, KM Biologics mainly produces vaccines for humans and veterinary use. It has an inactivated COVID-19 shot currently in development.